Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Eur+Urol 2016 ; 69 (4): 646-57 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer #MMPMID26298207
Eur Urol 2016[Apr]; 69 (4): 646-57 PMID26298207show ga
Context: Renal cancer is a common urologic malignancy, and therapeutic options for metastatic disease are limited. Most clear cell renal cell carcinomas (ccRCC) are associated with loss of von Hippel-Lindau tumor suppressor (pVHL) function and deregulation of hypoxia pathways. Objective: This review summarizes recent evidence from genetic and biological studies showing that hypoxia and hypoxia-related pathways play critical roles in the development and progress of renal cancer. Evidence acquisition: We used a systematic search for articles using the keywords hypoxia, HIF, renal cancer, and VHL. Evidence synthesis: Identification of the tumor suppressor pVHL has allowed the characterization of important ccRCC-associated pathways. pVHL targets ?-subunits of hypoxia-inducible transcription factors (HIF) for proteasomal degradation. The two main HIF-? isoforms have opposing effects on RCC biology, possibly through distinct interactions with additional oncogenes. Furthermore, HIF-1? activity is commonly diminished by chromosomal deletion in ccRCCs, and increased HIF-1 activity reduces tumor burden in xenograft tumor models. Conversely, polymorphisms at the HIF-2? gene locus predispose to the development of ccRCCs, and HIF-2? promotes tumor growth. Genetic studies have revealed a prominent role for chromatin-modifying enzyme genes in ccRCC, and these may further modulate specific aspects of the HIF response. This suggests that, rather than global activation of HIF, specific components of the response are important in promoting kidney cancer. Some of these processes are already targets for current therapeutic strategies, and further dissection of this pathway might yield novel methods of treating RCC. Conclusions: In contrast to many tumor types, HIF-1? and HIF-2? have opposing effects in ccRCC biology, with HIF-1? acting as a tumor suppressor and HIF-2? acting as an oncogene. The overall effect of VHL inactivation will depend on fine-tuning of the HIF response. Patient summary: High levels of hypoxia-inducible transcription factors (HIF) are particularly important in the clear cell type of kidney cancer, in which they are no longer properly regulated by the von Hippel-Lindau protein. The two HIF-? proteins have opposing effects on tumor evolution.
free
free
free
Eur+Urol 2016 ; 69 (4): 646-57
